Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Equity (2019 - 2025)

Historic Return on Equity for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to 0.4%.

  • Bicycle Therapeutics' Return on Equity fell 2000.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.3% for FY2024, which is 2600.0% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Return on Equity of 0.4% as of Q3 2025, which was down 2000.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Return on Equity ranged from a high of 0.2% in Q3 2024 and a low of 0.63% during Q2 2023
  • Over the past 5 years, Bicycle Therapeutics' median Return on Equity value was 0.4% (recorded in 2025), while the average stood at 0.38%.
  • In the last 5 years, Bicycle Therapeutics' Return on Equity plummeted by -3600bps in 2023 and then skyrocketed by 3600bps in 2024.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Return on Equity stood at 0.26% in 2021, then tumbled by -63bps to 0.43% in 2022, then dropped by -8bps to 0.46% in 2023, then surged by 53bps to 0.22% in 2024, then crashed by -85bps to 0.4% in 2025.
  • Its Return on Equity was 0.4% in Q3 2025, compared to 0.35% in Q2 2025 and 0.27% in Q1 2025.